Alentis Therapeutics logo

Alentis Therapeutics Employee Directory

Pharmaceutical ManufacturingBasel-Landschaft, Switzerland51-200 Employees

Alentis Therapeutics is a clinical-stage biotechnology company developing therapies that target Claudin-1 for cancer and multi-organ fibrosis. Its approach centers on antibody-drug conjugates and antibodies directed at CLDN1, an underexploited target implicated in the pathology of cancer and fibrotic disease. The company is headquartered in Allschwil, in the Basel-Landschaft region.

Operating in the pharmaceutical development arena, Alentis pursues therapies for oncology and fibrosis indications where CLDN1 biology may influence disease progression. In October 2025, the company appointed Mark Pruzanski, MD, as Chief Executive Officer, reflecting leadership changes to advance its clinical program.

Find Alentis Therapeutics employees' phone numbers or email addresses

Alentis Therapeutics Global Highlights

Location
Employees

Europe
56

Minus sign iconPlus sign icon
  • Switzerland
    45
  • France
    5
  • United Kingdom Of Great Britain And Northern Ireland
    4
  • Italy
    1
  • Netherlands
    1

North America
10

Minus sign iconPlus sign icon
  • United States Of America
    10

Asia
2

Minus sign iconPlus sign icon
  • India
    2

Alentis Therapeutics's Leadership

  • Cmo at Alentis Therapeutics
    L. M.
    Cmo
  • Chief Scientific Officer at Alentis Therapeutics
    A. T.
    Chief Scientific Officer
  • Chief Technology Officer at Alentis Therapeutics
    R. M.
    Chief Technology Officer
  • Vice President Program Management at Alentis Therapeutics
    M. A.
    Vice President Program Management
  • Vp Oncology Clinical Development at Alentis Therapeutics
    A. Z.
    Vp Oncology Clinical Development
  • Head Of Communications at Alentis Therapeutics
    S. W.
    Head Of Communications
  • Head Of Regulatory Affairs at Alentis Therapeutics
    S. A.
    Head Of Regulatory Affairs
  • Head Of Clinical Operations, Fibrosis at Alentis Therapeutics
    D. S.
    Head Of Clinical Operations, Fibrosis

Alentis Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Entrepreneurship
  • Business
  • Program & Project Management
  • Business Development
  • Other
  • Community & Social Services

Contact profiles from Alentis Therapeutics

Name
Title
Contact
Location
Last Update
  • Head Of Communications at Alentis Therapeutics
    S. W.
    Head Of Communications
    Netherlands, North Holland
    Jul 29, 2026
  • Head Of Regulatory Affairs at Alentis Therapeutics
    S. A.
    Head Of Regulatory Affairs
    Switzerland, Zug
    Aug 19, 2026
  • Head Of Clinical Operations, Fibrosis at Alentis Therapeutics
    D. S.
    Head Of Clinical Operations, Fibrosis
    Switzerland, Basel-City
    Aug 13, 2026
  • Head Finance at Alentis Therapeutics
    M. J.
    Head Finance
    Switzerland, Zurich
    Aug 18, 2026
  • Director Translational Data Science at Alentis Therapeutics
    V. A.
    Director Translational Data Science
    France, Île-de-France
    Aug 18, 2026
  • Senior Director, Translational Research at Alentis Therapeutics
    C. H.
    Senior Director, Translational Research
    France
    Aug 18, 2026
  • Director Cmc Operations at Alentis Therapeutics
    S. W.
    Director Cmc Operations
    Switzerland, Basel-City
    Jul 29, 2026
  • Senior Director Business Development at Alentis Therapeutics
    S. A.
    Senior Director Business Development
    Switzerland, Basel-City
    Jul 29, 2026
  • Senior Director Project Management at Alentis Therapeutics
    A. Ł.
    Senior Director Project Management
    Aug 15, 2026
  • Director Of Qa at Alentis Therapeutics
    I. H.
    Director Of Qa
    Switzerland, Basel-Landschaft
    Jul 29, 2026

Frequently Asked Questions

What is Alentis Therapeutics known for?

Minus sign iconPlus sign icon
Alentis Therapeutics was founded in 2019 and operates in the Pharmaceutical Manufacturing industry. Explore Alentis Therapeutics's company overview page for more information.

What is Alentis Therapeutics's most common email format?

Minus sign iconPlus sign icon
Alentis Therapeutics employees' email format typically follows the pattern of First.Last@alentis.ch. Trying to find reliable and up-to-date employee contact data? Find more Alentis Therapeutics email formats with LeadIQ.

How many employees does Alentis Therapeutics have currently?

Minus sign iconPlus sign icon
Alentis Therapeutics has approximately 72 employees as of August 2026. These team members are located across 3 continents, including Europe, North America and Asia.

Who are Alentis Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Alentis Therapeutics's key employees include:

  • Cmo: L. M.
  • Chief Scientific Officer: A. T.
  • Chief Technology Officer: R. M.
  • Vice President Program Management: M. A.
  • Vp Oncology Clinical Development: A. Z.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.